Implantable drug delivery devices Market - Global Industry Analysis

Implantable drug delivery devices Market By Product (Drug Infusion Pumps, Drug Delivery Devices, Bio-Absorbable Stents, Coronary Drug Eluting Stents, Brachytherapy Seeds, Contraceptive Drug Delivery Implants, and Others), By End-user (Oncology, Contraception, Cardiovascular, Ophthalmology, Inflammatory Conditions, Diabetes, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028

Published Date: 16-Jul-2021 Category: Medical Device Report Format : PDF Pages: 145 Report Code: ZMR-120 Status : Published

The global Implantable drug delivery devices market accounted for USD 14.9 Billion in 2020 and is expected to reach USD 26.7 Billion by 2028, growing at a CAGR of around 7.5% between 2021 and 2028.

Description

Market Overview     

The global Implantable drug delivery devices market accounted for USD 14.9 Billion in 2020 and is expected to reach USD 26.7 Billion by 2028, growing at a CAGR of around 7.5% between 2021 and 2028.      

With the help of implantable drug delivery devices, it has become possible to have site-specific drug delivery. This is of great importance in cardiology and oncology. Implantable drug delivery devices help in the constant release of a therapeutic agent. Implantable drug delivery devices require smaller dosages as compared its counterpart which in turn reduces the probability of side effects from drugs.  Implantable drug delivery devices are used in a number of applications including HIV/AIDS prevention, diabetes management, chronic pain management, central nervous system (CNS) health, oncology, contraception, and cardiology.

COVID-19 Impact Analysis  

The restrictions imposed by various nations to contain COVID had stopped the demand and supply resulting in a disruption across the whole supply chain. However, the global markets are slowly opening to their full potential and theirs a surge in demand. The market would remain bullish in upcoming year.  The global Implantable drug delivery devices market has witnessed a slight decline in the sales for short term to the lockdown enforcement placed by governments in order to contain COVID spreading. The restrictions imposed by various nations to contain COVID had stopped the production resulting in a disruption across the whole supply chain.  However, the global markets are slowly opening to their full potential and theirs a surge in demand. The market would remain bullish in upcoming year. The significant decrease in the global Implantable drug delivery devices market size in 2020 is estimated on the basis of the COVID-19 outbreak and its negative impact on the economies and industries across the globe. Various scenarios have been analyzed on the basis of inputs from various secondary sources and the current data available about the situation.  

Growth Factors

Global implantable drug delivery devices market is primarily driven by growing aging population and prevalence of target diseases such as diabetic retinopathy and chronic diseases. Other major driving factors for growth of implantable drug delivery devices market is rising cases of unwanted pregnancies. However, strict government regulations implied on this industry and the high cost of these devices are major restraints that may curb the growth of the market.

Nonetheless, the introduction of new and more effective implantable drug delivery devices is likely to disclose the new avenues for implantable drug delivery devices market in the near future.

Report Scope:  

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Segment Analysis Preview  

The implantable drug delivery devices market is segmented on the basis of different products including drug infusion pumps, drug delivery devices, bio-absorbable stents, coronary drug eluting stents, brachytherapy seeds, contraceptive drug delivery implants and others. In 2020, implantable drugs infusion pumps were the largest segment of implantable drug delivery devices market and accounted for largest share of the total market. Additionally, it is expected to continue its dominance and be the fastest growing segment in the global market over the forecast period.  Contraceptive drug delivery device is another major product segment of implantable drug delivery devices.

 Oncology, birth control/contraception, cardiovascular, ophthalmology, inflammatory conditions, diabetes and others are the key end-user segment of the global implantable drug delivery devices market. The cardiovascular end-user segment dominated the market in terms of revenue. The cardiovascular segment is likely to have a significant growth within the forecast period and is projected to the fastest growing segment as a result of increasing usage of bio-absorbable stents.

Regional Analysis Preview  

North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa are key regional segments of global implantable drug delivery devices market. North America is expected to remain the dominant region over the forecast period. Europe was a second largest market for implantable drug delivery devices in 2020. Asia Pacific is expected to be the fastest growing region in implantable drug delivery devices market during the forecast period. Moreover, Latin America is also expected to show noticeable growth for this market in the years to come.

Key Market Players & Competitive Landscape

Some of the major players of the global implantable drug delivery devices market include Bausch & Lomb Inc., Medtronic Inc, Boston Scientific Corporation, Arrow International, Theragenics, Varian Medical Systems, Allergan Inc, Merck, Bayer Healthcare, Abbott laboratories among others.

The global Implantable drug delivery devices Market is segmented as follows:

By Products

  • Drug Infusion Pumps
  • Drug Delivery Devices
  • Bio-Absorbable Stents
  • Coronary Drug Eluting Stents
  • Brachytherapy Seeds
  • Contraceptive Drug Delivery Implants
  • Others

By End-users

  • Oncology
  • Contraception
  • Cardiovascular
  • Ophthalmology
  • Inflammatory Conditions
  • Diabetes
  • Others

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Product
        • 2.1.1.2. Market Attractiveness Analysis, By End-user
        • 2.1.1.3. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Implantable drug delivery devices Market, 2016 – 2028 (USD Billion)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Implantable drug delivery devices Market – Product Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Product, 2020 & 2028
    • 4.2. Drug Infusion Pumps
      • 4.2.1. Market Size and Forecast, By Region (USD Billion)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Drug Delivery Devices
      • 4.3.1. Market Size and Forecast, By Region (USD Billion)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.4. Bio-Absorbable Stents
      • 4.4.1. Market Size and Forecast, By Region (USD Billion)
      • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.5. Coronary Drug Eluting Stents
      • 4.5.1. Market Size and Forecast, By Region (USD Billion)
      • 4.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.6. Brachytherapy Seeds
      • 4.6.1. Market Size and Forecast, By Region (USD Billion)
      • 4.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.6.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.7. Contraceptive Drug Delivery Implants
      • 4.7.1. Market Size and Forecast, By Region (USD Billion)
      • 4.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.7.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.8. Others
      • 4.8.1. Market Size and Forecast, By Region (USD Billion)
      • 4.8.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.8.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 Implantable drug delivery devices Market – End-user Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By End-user, 2020 & 2028
    • 5.2. Onculogy
      • 5.2.1. Market Size and Forecast, By Region (USD Billion)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Contraception
      • 5.3.1. Market Size and Forecast, By Region (USD Billion)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Cardiovascular
      • 5.4.1. Market Size and Forecast, By Region (USD Billion)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.5. Ophthalmulogy
      • 5.5.1. Market Size and Forecast, By Region (USD Billion)
      • 5.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.6. Inflammatory Conditions
      • 5.6.1. Market Size and Forecast, By Region (USD Billion)
      • 5.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.6.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.7. Contraceptive Drug Delivery Implants
      • 5.7.1. Market Size and Forecast, By Region (USD Billion)
      • 5.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.7.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.7. Others
      • 5.7.1. Market Size and Forecast, By Region (USD Billion)
      • 5.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.7.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.1. Overview
      • 6.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 6.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Billion)
    • 6.2. North America
      • 6.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.2.2. North America Market Revenue, By Product, 2016 – 2028
      • 6.2.3. North America Market Revenue, By End-user, 2016 – 2028
      • 6.2.5. U.S.
        • 6.2.5.1. U.S. Market Revenue, By Product, 2016 – 2028
        • 6.2.5.2. U.S. Market Revenue, By End-user, 2016 – 2028
      • 6.2.6. Canada
        • 6.2.6.1. Canada Market Revenue, By Product, 2016 – 2028
        • 6.2.6.2. Canada Market Revenue, By End-user, 2016 – 2028
      • 6.2.7. Mexico
        • 6.2.7.1. Mexico Market Revenue, By Product, 2016 – 2028
        • 6.2.7.2. Mexico Market Revenue, By End-user, 2016 – 2028
    • 6.3. Europe
      • 6.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.3.2. Europe Market Revenue, By Product, 2016 – 2028
      • 6.3.3. Europe Market Revenue, By End-user, 2016 – 2028
      • 6.3.5. Germany
        • 6.3.5.1. Germany Market Revenue, By Product, 2016 – 2028
        • 6.3.5.2. Germany Market Revenue, By End-user, 2016 – 2028
      • 6.3.6. France
        • 6.3.6.1. France Market Revenue, By Product, 2016 – 2028
        • 6.3.6.2. France Market Revenue, By End-user, 2016 – 2028
      • 6.3.7. U.K.
        • 6.3.7.1. U.K. Market Revenue, By Product, 2016 – 2028
        • 6.3.7.2. U.K. Market Revenue, By End-user, 2016 – 2028
      • 6.3.8. Italy
        • 6.3.8.1. Italy Market Revenue, By Product, 2016 – 2028
        • 6.3.8.2. Italy Market Revenue, By End-user, 2016 – 2028
      • 6.3.9. Spain
        • 6.3.9.1. Spain Market Revenue, By Product, 2016 – 2028
        • 6.3.9.2. Spain Market Revenue, By End-user, 2016 – 2028
      • 6.3.10. Rest of Europe
        • 6.3.10.1. Rest of Europe Market Revenue, By Product, 2016 – 2028
        • 6.3.10.2. Rest of Europe Market Revenue, By End-user, 2016 – 2028
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.4.2. Asia Pacific Market Revenue, By Product, 2016 – 2028
      • 6.4.3. Asia Pacific Market Revenue, By End-user, 2016 – 2028
      • 6.4.5. China
        • 6.4.5.1. China Market Revenue, By Product, 2016 – 2028
        • 6.4.5.2. China Market Revenue, By End-user, 2016 – 2028
      • 6.4.6. Japan
        • 6.4.6.1. Japan Market Revenue, By Product, 2016 – 2028
        • 6.4.6.2. Japan Market Revenue, By End-user, 2016 – 2028
      • 6.4.7. India
        • 6.4.7.1. India Market Revenue, By Product, 2016 – 2028
        • 6.4.7.2. India Market Revenue, By End-user, 2016 – 2028
      • 6.4.8. South Korea
        • 6.4.8.1. South Korea Market Revenue, By Product, 2016 – 2028
        • 6.4.8.2. South Korea Market Revenue, By End-user, 2016 – 2028
      • 6.4.9. South-East Asia
        • 6.4.9.1. South-East Asia Market Revenue, By Product, 2016 – 2028
        • 6.4.9.2. South-East Asia Market Revenue, By End-user, 2016 – 2028
      • 6.4.10. Rest of Asia Pacific
        • 6.4.10.1. Rest of Asia Pacific Market Revenue, By Product, 2016 – 2028
        • 6.4.10.2. Rest of Asia Pacific Market Revenue, By End-user, 2016 – 2028
    • 6.5. Latin America
      • 6.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.5.2. Latin America Market Revenue, By Product, 2016 – 2028
      • 6.5.3. Latin America Market Revenue, By End-user, 2016 – 2028
      • 6.5.5. Brazil
        • 6.5.5.1. Brazil Market Revenue, By Product, 2016 – 2028
        • 6.5.5.2. Brazil Market Revenue, By End-user, 2016 – 2028
      • 6.5.6. Argentina
        • 6.5.6.1. Argentina Market Revenue, By Product, 2016 – 2028
        • 6.5.6.2. Argentina Market Revenue, By End-user, 2016 – 2028
      • 6.5.7. Rest of Latin America
        • 6.5.7.1. Rest of Latin America Market Revenue, By Product, 2016 – 2028
        • 6.5.7.2. Rest of Latin America Market Revenue, By End-user, 2016 – 2028
    • 6.6. The Middle-East and Africa
      • 6.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.6.2. The Middle-East and Africa Market Revenue, By Product, 2016 – 2028
      • 6.6.3. The Middle-East and Africa Market Revenue, By End-user, 2016 – 2028
      • 6.6.5. GCC Countries
        • 6.6.5.1. GCC Countries Market Revenue, By Product, 2016 – 2028
        • 6.6.5.2. GCC Countries Market Revenue, By End-user, 2016 – 2028
      • 6.6.6. South Africa
        • 6.6.6.1. South Africa Market Revenue, By Product, 2016 – 2028
        • 6.6.6.2. South Africa Market Revenue, By End-user, 2016 – 2028
      • 6.6.7. Rest of Middle-East Africa
        • 6.6.7.1. Rest of Middle-East Africa Market Revenue, By Product, 2016 – 2028
        • 6.6.7.2. Rest of Middle-East Africa Market Revenue, By End-user, 2016 – 2028
  • Chapter No. 7: Implantable drug delivery devices Market – Industry Analysis
    • 7.1. Introduction
    • 7.2. Market Drivers
      • 7.2.1. Driving Factor 1 Analysis
      • 7.2.2. Driving Factor 2 Analysis
    • 7.3. Market Restraints
      • 7.3.1. Restraining Factor Analysis
    • 7.4. Market Opportunities
      • 7.4.1. Market Opportunity Analysis
    • 7.5. Porter’s Five Forces Analysis
    • 7.6. PEST Analysis
    • 7.7. Regulatory Landscape
    • 7.8. Technology Landscape
    • 7.9. Regional Market Trends
      • 7.9.1. North America
      • 7.9.2. Europe
      • 7.9.3. Asia Pacific
      • 7.9.4. Latin America
      • 7.9.5. The Middle-East and Africa
    • 7.10. Pricing Analysis
    • 7.11. Value Chain Analysis
    • 7.12. Downstream Buyers
    • 7.13. Distributors/Traders List
  • Chapter No. 8: Competitive Landscape
    • 8.1. Company Market Share Analysis – 2019
      • 8.1.1. Global Implantable drug delivery devices Market: Company Market Share, 2019
      • 8.1.2. Global Implantable drug delivery devices Market, Company Market Revenue, 2016 – 2019 (USD Billion)
      • 8.1.3. Global Implantable drug delivery devices Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 8.1.4. Global Implantable drug delivery devices Market: Radar Determinant Chart, 2019
    • 8.2. Strategic Developments
      • 8.2.1. Acquisitions & Mergers
      • 8.2.2. New Product Launch
      • 8.2.3. Regional Expansion
    • 8.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 9: Company Profiles
    • 9.1. Bausch & Lomb Inc.
      • 9.1.1. Company Overview
      • 9.1.2. Key Executives
      • 9.1.3. Product Portfolio
      • 9.1.4. Financial Overview
      • 9.1.5. Operating Business Segments
      • 9.1.6. Business Performance
      • 9.1.7. Recent Developments
    • 9.2. Dickinson and Company
    • 9.3. Medtronic Inc.
    • 9.4. Boston Scientific Corporation
    • 9.5. Arrow International
    • 9.6. Theragenics
    • 9.7. Varian Medical Systems
    • 9.8. Allergan Inc.
    • 9.9. Merck
    • 9.10. Bayer Healthcare
    • 9.11 Abbott laboratories
  • Chapter No. 10: Marketing Strategy Analysis
    • 10.1. Marketing Channel
    • 10.2. Direct Marketing
    • 10.3. Indirect Marketing
    • 10.4. Marketing Channel Development Trends
    • 10.5. Economic/Pulitical Environmental Change
  • Chapter No. 11: Research Methodology
    • 11.1. Research Methodology
    • 11.2. Phase I - Secondary Research
    • 11.3. Phase II - Data Modeling
      • 11.3.1. Company Share Analysis Model
      • 11.3.2. Revenue Based Modeling
    • 11.4. Phase III - Primary Research
    • 11.5. Research Limitations
      • 11.5.1. Assumptions

Table Of Figures

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Product
FIG NO. 2. Market Attractiveness Analysis, By End-user
FIG NO. 3. Market Attractiveness Analysis, By Region
FIG NO. 4. Global Implantable drug delivery devices Market Revenue, 2016 – 2028 (USD Billion)
FIG NO. 5. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 6. Market Revenue Share, By Product, 2020 & 2028 
FIG NO. 7. Global Implantable drug delivery devices Market for Drug Infusion Pumps, Revenue (USD Billion) 2016 – 2028
FIG NO. 8. Comparative Revenue Analysis of Implantable drug delivery devices Market for Drug Infusion Pumps, By Country, 2020 & 2028
FIG NO. 9. Global Implantable drug delivery devices Market for Drug Delivery Devices, Revenue (USD Billion) 2016 – 2028
FIG NO. 10. Comparative Revenue Analysis of Implantable drug delivery devices Market for Drug Delivery Devices, By Country, 2020 & 2028
FIG NO. 11. Global Implantable drug delivery devices Market for Bio-Absorbable Stents, Revenue (USD Billion) 2016 – 2028
FIG NO. 12. Comparative Revenue Analysis of Implantable drug delivery devices Market for Bio-Absorbable Stents, By Country, 2020 & 2028
FIG NO. 13. Global Implantable drug delivery devices Market for Coronary Drug Eluting Stents, Revenue (USD Billion) 2016 – 2028
FIG NO. 14. Comparative Revenue Analysis of Implantable drug delivery devices Market for Coronary Drug Eluting Stents, By Country, 2020 & 2028
FIG NO. 15. Global Implantable drug delivery devices Market for Brachytherapy Seeds, Revenue (USD Billion) 2016 – 2028
FIG NO. 16. Comparative Revenue Analysis of Implantable drug delivery devices Market for Brachytherapy Seeds, By Country, 2020 & 2028
FIG NO. 17. Global Implantable drug delivery devices Market for Others, Revenue (USD Billion) 2016 – 2028
FIG NO. 18. Comparative Revenue Analysis of Implantable drug delivery devices Market for Others, By Country, 2020 & 2028
FIG NO. 19. Global Implantable drug delivery devices Market for Contraceptive Drug Delivery Implants, Revenue (USD Billion) 2016 – 2028
FIG NO. 20. Comparative Revenue Analysis of Implantable drug delivery devices Market for Contraceptive Drug Delivery Implants, By Country, 2020 & 2028
FIG NO. 21. Market Revenue Share, By End-user, 2020 & 2028
FIG NO. 22. Global Implantable drug delivery devices Market for Oncology, Revenue (USD Billion) 2016 – 2028
FIG NO. 23. Comparative Revenue Analysis of Implantable drug delivery devices Market for Oncology, By Country, 2020 & 2028 
FIG NO. 24. Global Implantable drug delivery devices Market for Contraception, Revenue (USD Billion) 2016 – 2028
FIG NO. 25. Comparative Revenue Analysis of Implantable drug delivery devices Market for Contraception, By Country, 2020 & 2028
FIG NO. 26. Global Implantable drug delivery devices Market for Cardiovascular, Revenue (USD Billion) 2016 – 2028 
FIG NO. 27. Comparative Revenue Analysis of Implantable drug delivery devices Market for Cardiovascular, By Country, 2020 & 2028
FIG NO. 28. Global Implantable drug delivery devices Market for Ophthalmology, Revenue (USD Billion) 2016 – 2028
FIG NO. 29. Comparative Revenue Analysis of Implantable drug delivery devices Market for Ophthalmology, By Country, 2020 & 2028
FIG NO. 30. Global Implantable drug delivery devices Market for Inflammatory Conditions, Revenue (USD Billion) 2016 – 2028
FIG NO. 31. Comparative Revenue Analysis of Implantable drug delivery devices Market for Inflammatory Conditions, By Country, 2020 & 2028
FIG NO. 32. Global Implantable drug delivery devices Market for Diabetes, Revenue (USD Billion) 2016 – 2028
FIG NO. 33. Comparative Revenue Analysis of Implantable drug delivery devices Market for Diabetes, By Country, 2020 & 2028
FIG NO. 34. Global Implantable drug delivery devices Market for Others, Revenue (USD Billion) 2016 – 2028
FIG NO. 35. Comparative Revenue Analysis of Implantable drug delivery devices Market for Others, By Country, 2020 & 2028
FIG NO. 36. Global Implantable drug delivery devices Market Revenue Share, By Region, 2020 & 2028
FIG NO. 37. North America Implantable drug delivery devices Market Revenue, 2016 - 2028 (USD Billion)
FIG NO. 38. Porter’s Five Forces Analysis for Global Implantable drug delivery devices Market
FIG NO. 39. PEST Analysis for Global Implantable drug delivery devices Market
FIG NO. 40. Pricing Analysis for Global Implantable drug delivery devices Market
FIG NO. 41. Value Chain Analysis for Global Implantable drug delivery devices Market
FIG NO. 42. Company Share Analysis, 2019
FIG NO. 43. Radar Determinant Chart, 2019
FIG NO. 44. Company Strategic Developments – Heat Map Analysis
FIG NO. 45. Bausch & Lomb Inc. Business Segment Revenue Share, 2020 (%)
FIG NO. 46. Bausch & Lomb Inc. Geographical Segment Revenue Share, 2020 (%)
FIG NO. 47. Market Channels
FIG NO. 48. Marketing Channel Development Trend
FIG NO. 49. Growth in World Gross Product, 2008-2018
FIG NO. 50. Research Methodology – Detailed View
FIG NO. 51. Research Methodology
 


Table Of Tables

List of Tables 

TABLE NO. 1. Global Implantable drug delivery devices Market: Snapshot
TABLE NO. 2. Quarterly Implantable drug delivery devices Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Implantable drug delivery devices Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion) 
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion) 
TABLE NO. 6. Global Implantable drug delivery devices Market for Drug Infusion Pumps, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 7. Global Implantable drug delivery devices Market for Drug Delivery Devices, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 8. Global Implantable drug delivery devices Market for Bio-Absorbable Stents, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 9. Global Implantable drug delivery devices Market for Coronary Drug Eluting Stents, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 10. Global Implantable drug delivery devices Market for Brachytherapy Seeds, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 11: Global Implantable drug delivery devices Market for Contraceptive Drug Delivery Implants, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 12: Global Implantable drug delivery devices Market for others, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 13. Global Implantable drug delivery devices Market for Oncology, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 14 Global Implantable drug delivery devices Market for Contraception, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 15. Global Implantable drug delivery devices Market for Cardiovascular, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 16. Global Implantable drug delivery devices Market for Ophthalmology, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 17. Global Implantable drug delivery devices Market for Inflammatory Conditions, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 18. Global Implantable drug delivery devices Market for Diabetes, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 19. Global Implantable drug delivery devices Market for Others, by Region, 2016 – 2028 (USD Billion) 
TABLE NO. 20. Global Implantable drug delivery devices Market Revenue, By Region, 2016 – 2028 (USD Billion)
TABLE NO. 21. North America Implantable drug delivery devices Market Revenue, By Country, 2016 – 2028 (USD Billion)
TABLE NO. 22. North America Implantable drug delivery devices Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 23. North America Implantable drug delivery devices Market Revenue, By End-user, 2016 – 2028 (USD Billion)
TABLE NO. 24. U.S. Implantable drug delivery devices Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 25. U.S. Implantable drug delivery devices Market Revenue, By End-user, 2016 – 2028 (USD Billion)
TABLE NO. 26. Canada Implantable drug delivery devices Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 27. Canada Implantable drug delivery devices Market Revenue, By End-user, 2016 – 2028 (USD Billion)
TABLE NO. 28. Mexico Implantable drug delivery devices Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 29. Mexico Implantable drug delivery devices Market Revenue, By End-user, 2016 – 2028 (USD Billion)
TABLE NO. 30. Drivers for the Implantable drug delivery devices Market: Impact Analysis
TABLE NO. 31. Restraints for the Implantable drug delivery devices Market: Impact Analysis
TABLE NO. 32. Major Buyers of Implantable drug delivery devices  
TABLE NO. 33. Distributors/Traders List of Implantable drug delivery devices
TABLE NO. 34. Global Implantable drug delivery devices Market, Company Market Revenue, 2016 – 2019 (USD Billion)
TABLE NO. 35: Global Implantable drug delivery devices Market, Company Y-o-Y Growth, 2017 – 2019 (USD Billion)   


 

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Implantable Drug Delivery Devices market. Zion Research has collected and analyzed key data belong to the global Implantable Drug Delivery Devices market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined afterconducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account, while estimating market size. The revenue generated by the leading industry participants in from the sales of Implantable Drug Delivery Devices across the world has been calculated through primary and secondary research.

Zion Research employs combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include, STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assistedin validation of findings from secondary research and to understand key trends in the Implantable Drug Delivery Devices industry. Primary research makes up major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Implantable Drug Delivery Devices market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

Implantable drug delivery devices offer multiple advantages over conventional oral or parental drug delivery methods. Implantable drug delivery devices help to provide localized, site-specific drug delivery, which is of great importance in oncology and cardiology, where targeted delivery minimize side effects or damage to healthy tissue and help to improve the effectiveness of treatment. Moreover, the dosage required in implantable drug delivery devices is lower as compared to other modes of drug delivery which in turn lowers the chances of side effects. Implantable drug delivery devices are used in number of applications including HIV/AIDS prevention, diabetes management, chronic pain management, oncology, contraception, cardiology, and central nervous system (CNS) health.

Growing incidences of target disease such as diabetic retinopathy, prostate cancer, cardiovascular diseases and chronic diseases is expected to be the major drivers for the global implantable drug delivery devices market. In addition, growing geriatric population coupled along with rising cases of unwanted pregnancies is expected to trigger the growth of implantable drug delivery devices industry in the coming years. Moreover, increasing demand for minimally invasive procedures coupled along with technological innovations is expected to help implantable drug delivery devices industry steep growth in coming years. However, strict government regulations implied on this industry and high cost of these devices may pose the challenge to implantable drug delivery devices market. Nevertheless, introduction of new and more effective implantable drug delivery devices is expected to act an opportunity for implantable drug delivery devices market in near future.

Global ImplantableDrug Delivery Devices Market

Based on product, implantable drug delivery devices market has been segmented into drug infusion pumps, drug delivery devices, bio-absorbable stents, coronary drug eluting stents, brachytherapy seeds, contraceptive drug delivery implants and others.  Implantable drug delivery devices market was dominated by implantable drugs infusion pumps segment which accounted for largest share across the globe. Further it is expected to continue its dominance over the forecast period. 

The implantable drug delivery devices market is segmented into end-user such as oncology, birth control/contraception, cardiovascular, ophthalmology, inflammatory conditions, diabetes and other end-users. In terms of demand, the cardiovascular end-user segment dominated the market in 2015. Cardiovascular device is projected to be the fastest growing end-user segment as a result of increasing usage of bio-absorbable stents.

North America is expected to remain the dominant region over the forecast period. The U.S. is world’s largest market for biopharmaceutical. The strongly established pharmaceutical industry in this region offers good growth opportunities for implantable drug delivery devices in this region. Europe was second largest market for implantable drug delivery devices in 2015. Asia Pacific is projected to be the fastest growing region for implantable drug delivery devices market during the forecast period. As a result of increasing aging population and increasing health awareness in Brazil, Latin America is also expected to experience significant growth in the years to come.

Some of the key players in Bausch & Lomb Inc., Medtronic Inc, Boston Scientific Corporation, Arrow International, Theragenics, Varian Medical Systems, Allergan Inc, Merck, Bayer Healthcare, Abbott laboratories among others.

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

The global Implantable drug delivery devices Market was valued at USD 14.9 billion in 2020.

The global Implantable drug delivery devices Market is expected to reach USD 26.7 billion by 2028, growing at a CAGR of 7.5% between 2021 to 2028.

Some of the key factors driving the global Implantable drug delivery devices Market growth is growing aging population and prevalence of target diseases such as diabetic retinopathy and chronic diseases.

North America is expected to remain the dominant region over the forecast period. Europe was a second largest market for implantable drug delivery devices in 2020.

Some of the major players of global Implantable drug delivery devices market Bausch & Lomb Inc., Medtronic Inc, Boston Scientific Corporation, Arrow International, Theragenics, Varian Medical Systems, Allergan Inc, Merck, Bayer Healthcare, Abbott laboratories among others.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed